How big is the Cancer Diagnostics Market?

The Cancer Diagnostics Market size is expected to reach USD 106.24 billion in 2024 and grow at a CAGR of 8.12% to reach USD 156.97 billion by 2029. Read More

What is the current Cancer Diagnostics Market size?

In 2024, the Cancer Diagnostics Market size is expected to reach USD 106.24 billion. Read More

Who are the key players in Cancer Diagnostics Market?

F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Illumina Inc and bioMérieux SA are the major companies operating in the Cancer Diagnostics Market. Read More

Which is the fastest growing region in Cancer Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Cancer Diagnostics Market?

In 2024, the North America accounts for the largest market share in Cancer Diagnostics Market. Read More

What years does this Cancer Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Cancer Diagnostics Market size was estimated at USD 97.61 billion. The report covers the Cancer Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cancer Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Cancer Diagnostics Market Share

Statistics for the 2023 & 2024 Cancer Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Cancer Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Cancer Diagnostics Industry

The cancer diagnostics market is highly fragmented with the presence of a large number of local and international players. Key players are adopting different growth strategies to enhance their market presence such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientifica Inc., and Qiagen.